Prenatal exposure to the CB1 and CB2 cannabinoid receptor agonist WIN 55,212-2 alters migration of early-born glutamatergic neurons and GABAergic interneurons in the rat cerebral cortex

Journal of Neurochemistry

Volumn 129, Issue 4, 2014, Pages 637-648

  Saez, Trinidad M M ^a   Aronne, María P ^a   Caltana, Laura ^a   Brusco, Alicia H ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

cannabinoid; developing cerebral cortex; post mitotic migrating neurons; prenatal exposure

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 AMINOBUTYRIC ACID RECEPTOR; EOMESODERMIN; GLUTAMATE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TBR1; UNCLASSIFIED DRUG; BENZOXAZINE DERIVATIVE; CANNABINOID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; DOUBLECORTIN PROTEIN; ENDOCANNABINOID; GLUTAMIC ACID; MICROTUBULE ASSOCIATED PROTEIN; MORPHOLINE DERIVATIVE; NAPHTHALENE DERIVATIVE; NERVE CELL ADHESION MOLECULE; NERVE PROTEIN; NEUROPEPTIDE; REELIN PROTEIN; SCLEROPROTEIN; SERINE PROTEINASE; T BOX TRANSCRIPTION FACTOR; TBR 1 PROTEIN, RAT; TBR-1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN DEVELOPMENT; CELL COUNT; CELL DISRUPTION; CELL MIGRATION; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICOGENESIS; DORSAL PALLIUM; EMBRYO; FEMALE; INTERNEURON; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL DIVISION; CELL MOTION; CYTOLOGY; DEVELOPING CEREBRAL CORTEX; DRUG EFFECT; DRUG POTENTIATION; GENETIC TRANSCRIPTION; HIPPOCAMPUS; METABOLISM; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PHYSIOLOGY; POST-MITOTIC MIGRATING NEURONS; PREGNANCY; PRENATAL DEVELOPMENT; WISTAR RAT;

CANNABIS; CANNABIS SATIVA; RATTUS;

CANNABINOID; CB1 RECEPTOR; DEVELOPING CEREBRAL CORTEX; POST-MITOTIC MIGRATING NEURONS; PRENATAL EXPOSURE;

ANIMALS; APOPTOSIS; BENZOXAZINES; CANNABINOID RECEPTOR AGONISTS; CELL ADHESION MOLECULES, NEURONAL; CELL DIVISION; CELL MOVEMENT; CEREBRAL CORTEX; ENDOCANNABINOIDS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GABAERGIC NEURONS; GLUTAMIC ACID; HIPPOCAMPUS; INTERNEURONS; MICROTUBULE-ASSOCIATED PROTEINS; MORPHOLINES; NAPHTHALENES; NERVE TISSUE PROTEINS; NEUROGENESIS; NEURONS; NEUROPEPTIDES; PREGNANCY; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; SERINE ENDOPEPTIDASES; T-BOX DOMAIN PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84899493884     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12636     Document Type: Article

References (32)

1. Alvaro-Bartolome M., Esteban S., Garcia-Gutierrez M. S., Manzanares J., Valverde O., and, Garcia-Sevilla J. A., (2010) Regulation of Fas receptor/Fas-associated protein with death domain apoptotic complex and associated signalling systems by cannabinoid receptors in the mouse brain. Br. J. Pharmacol. 160, 643-656.
2. Antonelli T., Tanganelli S., Tomasini M. C., et al,. (2004) Long-term effects on cortical glutamate release induced by prenatal exposure to the cannabinoid receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl- methyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone: an in (Pubitemid 38229656)
3. Antonelli T., Tomasini M. C., Tattoli M., et al,. (2005) Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring. Cereb. Cortex 15, 2013-2020. (Pubitemid 41628339)
4. Berghuis P., Dobszay M. B., Wang X., et al,. (2005) Endocannabinoids regulate interneuron migration and morphogenesis by transactivating the TrkB receptor. Proc. Natl Acad. Sci. USA 102, 19115-19120. (Pubitemid 43049575)
5. Berghuis P., Rajnicek A. M., Morozov Y. M., et al,. (2007) Hardwiring the brain: endocannabinoids shape neuronal connectivity. Science 316, 1212-1216. (Pubitemid 46880959)
6. Campbell K., and, Gotz M., (2002) Radial glia: multi-purpose cells for vertebrate brain development. Trends Neurosci. 25, 235-238. (Pubitemid 34327796)
7. De Petrocellis L., and, Di Marzo V., (2009) An introduction to the endocannabinoid system: from the early to the latest concepts. Best Pract. Res. Clin. Endocrinol. Metab. 23, 1-15.
8. Diaz-Alonso J., Aguado T., Wu C. S., et al,. (2012) The CB(1) cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis. J. Neurosci. 32, 16651-16665.
9. El Marroun H., Hudziak J. J., Tiemeier H., et al,. (2011) Intrauterine cannabis exposure leads to more aggressive behavior and attention problems in 18-month-old girls. Drug Alcohol Depend. 118, 470-474.
10. Englund C., Fink A., Lau C., Pham D., Daza R. A. M., Bulfone A., Kowalczyk T., and, Hevner R. F., (2005) Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex. J. Neurosci. 25, 247-251. (Pubitemid 40110787)
11. Francis F., Koulakoff A., Boucher D., et al,. (1999) Doublecortin is a developmentally regulated, microtubule-associated protein expressed in migrating and differentiating neurons. Neuron 23, 247-256. (Pubitemid 29315721)
12. Hartfuss E., Forster E., Bock H. H., Hack M. A., Leprince P., Luque J. M., Herz J., Frotscher M., and, Gotz M., (2003) Reelin signaling directly affects radial glia morphology and biochemical maturation. Development 130, 4597-4609. (Pubitemid 37279413)
13. Hevner R. F., Shi L., Justice N., et al,. (2001) Tbr1 regulates differentiation of the preplate and layer 6. Neuron 29, 353-366. (Pubitemid 32206476)
14. Huizink A. C., (2013) Prenatal cannabis exposure and infant outcomes: overview of studies. Prog. Neuropsychopharmacol. Biol. Psychiatry, doi: 10.1016/j.pnpbp.2013.09.014.
15. Hutchings D. E., Martin B. R., Gamagaris Z., Miller N., and, Fico T., (1989) Plasma concentrations of delta-9-tetrahydrocannabinol in dams and fetuses following acute or multiple prenatal dosing in rats. Life Sci. 44, 697-701. (Pubitemid 19065969)
16. Jutras-Aswad D., DiNieri J., Harkany, T., and, Hurd, Y. L., (2009) Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. Eur. Arch. Psychiatry Clin. Neurosci. 259, 395-412.
17. Maj P. F., Collu M., Fadda P., Cattaneo A., Racagni G., and, Riva M. A., (2007) Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzoxazin-. Eur. J. Neurosci. 25, 3305-3311. (Pubitemid 46872765)
18. Manent J. B., Jorquera I., Ben-Ari Y., Aniksztejn L., and, Represa A., (2006) Glutamate acting on AMPA but not NMDA receptors modulates the migration of hippocampal interneurons. J. Neurosci. 26, 5901-5909. (Pubitemid 44318355)
19. Martini F. J., Valiente M., Lõpez Bendito G., Szabõ G., Moya F., Valdeolmillos M., and, Marín O., (2009) Biased selection of leading process branches mediates chemotaxis during tangential neuronal migration. Development 136, 41-50.
20. Mathews C. A., Scharf J. M., Miller L. L., Macdonald-Wallis C., Lawlor D. A., and, Ben-Shlomo Y., (2014) Association between pre- and perinatal exposures and Tourette syndrome or chronic tic disorder in the ALSPAC cohort. Br. J. Psychiatry, 204, 40-45.
21. Mereu G., Fà M., Ferraro L., et al,. (2003) Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release. Proc. Natl Acad. Sci. USA 100, 4915-4920. (Pubitemid 36457828)
22. Molyneaux B. J., Arlotta P., Menezes J. R. L., and, Macklis J. D., (2007) Neuronal subtype specification in the cerebral cortex. Nat. Rev. Neurosci. 8, 427-437. (Pubitemid 46789231)
23. Morozov Y. M., Torii M., and, Rakic P., (2009) Origin, early commitment, migratory routes, and destination of cannabinoid type 1 receptor-containing interneurons. Cereb. Cortex 19 (Suppl 1), i78-i89.
24. Mulder J., Aguado T., Keimpema E., et al,. (2008) Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc. Natl Acad. Sci. USA 105, 8760-8765. (Pubitemid 351987753)
25. Pertwee R. G., (2009) Emerging strategies for exploiting cannabinoid receptor agonists as medicines. Br. J. Pharmacol. 156, 397-411.
26. Sessa A., Mao C.-A., Colasante G., Nini A., Klein W. H., and, Broccoli V., (2010) Tbr2-positive intermediate (basal) neuronal progenitors safeguard cerebral cortex expansion by controlling amplification of pallial glutamatergic neurons and attraction of subpallial GABAergic interneurons. Genes Dev. 24, 1816-1826.
27. Shabani M., Hosseinmardi N., Haghani M., Shaibani V., and, Janahmadi M., (2011) Maternal exposure to the CB1 cannabinoid agonist WIN 55212-2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring. Neuroscience 172, 139-152.
28. Smith A. M., Fried P. A., Hogan M. J., and, Cameron I., (2006) Effects of prenatal marijuana on visuospatial working memory: an fMRI study in young adults. Neurotoxicol. Teratol. 28, 286-295.
29. Tanaka D., Nakaya Y., Yanagawa Y., Obata K., and, Murakami F., (2003) Multimodal tangential migration of neocortical GABAergic neurons independent of GPI-anchored proteins. Development 130, 5803-5813. (Pubitemid 37540853)
30. Trazzi S., Steger M., Mitrugno V. M., Bartesaghi R., and, Ciani E., (2010) CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT/glycogen synthase kinase-3beta/beta-catenin signaling. J. Biol. Chem. 285, 10098-10109.
31. Vitalis T., Lainé J., Simon A., Roland A., Leterrier C., and, Lenkei Z., (2008) The type 1 cannabinoid receptor is highly expressed in embryonic cortical projection neurons and negatively regulates neurite growth in vitro. Eur. J. Neurosci. 28, 1705-1718.
32. Wu C.-S., Zhu J., Wager-Miller J., Wang S., O'Leary D., Monory K., Lutz B., Mackie K., and, Lu H.-C., (2010) Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. Eur. J. Neurosci. 32, 693-706.